Dip Card BZO/300, Detecting Benzodiazepine. Serenity Rapid Urine Drug Screening Card

Benzodiazepines (BZO) Rapid Drug Test

Features:

• Rapid results in approximately 5 minutes
• 300 ng/mL cutoff level for detecting BZO (Benzodiazepines)
• User-friendly dip format for simple testing
• Also offered in single-panel strip versions
• High accuracy for consistent screening performance
• Same-day order fulfillment
• Free shipping on bulk orders of 100 or more
• FDA Approved and CLIA Waived

 What is BZO?

BZO (Benzodiazepines) are a class of prescription medications commonly used to treat anxiety, insomnia, seizures, and other neurological conditions. These drugs work by calming the central nervous system, producing sedative and relaxing effects. While effective when used as directed, benzodiazepines may be subject to misuse, which can lead to dependence and impaired cognitive or motor function.

12 Panel Now provides a reliable BZO Rapid Drug Test Dip Card designed to detect benzodiazepines at a 300 ng/mL cutoff level, offering accurate and consistent results.

Benzodiazepines Drug Test Dip Card

Accurate Detection of Benzodiazepines

The BZO Dip Card is designed to quickly identify the presence of benzodiazepines in urine samples. These substances are widely prescribed but can impair alertness, coordination, and reaction time when misused. Prolonged or improper use may result in tolerance, dependence, and withdrawal symptoms.

With a 300 ng/mL cutoff level, this test ensures precise detection for clinical settings.

Why It’s Important to Test

Testing for benzodiazepines is important for maintaining safety and compliance in regulated environments. Although these medications are commonly prescribed, misuse can affect performance, decision-making, and overall well-being.

A 300 ng/mL cutoff level provides reliable detection of recent use, supporting monitoring programs and helping professionals make informed decisions.

What You Should Know

Benzodiazepines are effective medications when used under medical supervision, but they carry risks when misused. Potential effects include drowsiness, confusion, slowed reaction time, and respiratory depression, particularly when combined with other substances. Long-term misuse may also lead to dependence.

Because of these risks, dependable testing with a 300 ng/mL cutoff level is essential for early detection and maintaining safety in professional environments.

How to Use a BZO Dip Test

1. Remove the dip card from the sealed pouch and take off the protective cap.
2. Dip the exposed test strips into a urine sample for 10–15 seconds.
3. Allow the sample to travel up the test strips.
4. Replace the cap and lay the device flat on a clean, non-absorbent surface.
5. Wait 5 minutes before reading the results.

CLINICAL USE PRODUCT

This product is FDA Approved and CLIA Waived, making it suitable for use in clinical settings, physician offices, and workplace testing programs.

CLIA Waived status indicates that the test is simple to perform and provides accurate results with minimal risk of user error when instructions are followed. These tests are commonly used in point-of-care environments for rapid screening purposes.

This device is not designated for forensic use.

Why Choose Our BZO Test?

The BZO Drug Test Dip Card provides a fast and dependable solution for detecting benzodiazepines. Its simple dip-and-read design allows for efficient testing with clear results in minutes. The 300 ng/mL cutoff level ensures accurate and consistent performance across a variety of professional applications.

The 12PanelNow Advantage

12 Panel Now is committed to offering high-quality drug testing products at competitive prices. Our selection includes both single-panel and multi-panel devices, all produced under strict quality control standards. Customers benefit from reliable performance, cost-effective bulk options, and responsive support.